Jeffrey W. Sherman
2013
In 2013, Jeffrey W. Sherman earned a total compensation of $916.3K as Executive Vice President, Development, Manufacturing and Regulatory Affairs, and Chief Medical Officer at Horizon Pharma, a 7% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $198,172 |
---|---|
Option Awards | $89,250 |
Salary | $396,340 |
Stock Awards | $231,914 |
Other | $600 |
Total | $916,276 |
Sherman received $396.3K in salary, accounting for 43% of the total pay in 2013.
Sherman also received $198.2K in non-equity incentive plan, $89.3K in option awards, $231.9K in stock awards and $600 in other compensation.
Rankings
In 2013, Jeffrey W. Sherman's compensation ranked 7,024th out of 12,286 executives tracked by ExecPay. In other words, Sherman earned more than 42.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,024 out of 12,286 | 43rd |
Division Manufacturing | 2,499 out of 4,612 | 46th |
Major group Chemicals And Allied Products | 762 out of 1,462 | 48th |
Industry group Drugs | 564 out of 1,156 | 51st |
Industry Pharmaceutical Preparations | 451 out of 890 | 49th |
Source: SEC filing on June 2, 2014.
Sherman's colleagues
We found four more compensation records of executives who worked with Jeffrey W. Sherman at Horizon Pharma in 2013.
2013
Timothy Walbert
Horizon Pharma
Chief Executive Officer
2013
Todd Smith
Horizon Pharma
Executive Vice President and Chief Commercial Officer
2013
Robert De Vaere
Horizon Pharma
Chief Financial Officer
2013
Michael Adatto
Horizon Pharma